Developer of biosimilar theraputics
S. 771 - A bill to improve access to affordable prescription drugs - issues related to ensuring a healthy market for biosimilar medications. 

Issues related to the upcoming biosimilars User Fee Agreement legislation. 

Issues related to the treatment of biosimilar medications in Medicare Part B and D programs. 

Issues related to the maintenance of current IPR laws. S. 771 - A bill to improve access to affordable prescription drugs - issues related to ensuring a healthy market for biosimilar medications. 

Issues related to the upcoming biosimilars User Fee Agreement legislation. 

Issues related to the treatment of biosimilar medications in Medicare Part B and D programs. 

Issues related to the maintenance of current IPR laws. S. 771 - A bill to improve access to affordable prescription drugs - issues related to ensuring a healthy market for biosimilar medications. 

Issues related to the treatment of biosimilar medications in Medicare Part B and D programs.
HCR - Health Issues PHA - Pharmacy MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
NATHANSON+HAUCK
601 13th Street NW, Suite 290 North, Washington, DC, 20005, US
MEGAN HAUCK MARSHALL MELANIE JAN NATHANSON MEGAN HAUCK MARSHALL MELANIE JAN NATHANSON MEGAN HAUCK MARSHALL MELANIE JAN NATHANSON